{
    "medicine_id": "03384509f71d02970a3b0ee1d88ad89e54b26a70",
    "platform_id": "DB01077",
    "metadata": {
        "name": "Act Etidrocal 200 mg Tablet",
        "composition": "200 mg Etidronic acid",
        "clinical_particulars": {
            "therapeutic_indications": "Etidronate is indicated to treat Paget s disease of bone as well as the treatment and prevention of heterotropic ossification after total hip replacement of spinal cord injury L13901",
            "contraindications": {
                "disease": "Patients experiencing an overdose may present with hypocalcemia vomiting parasthesia and diarrhea L13901 Overdose can be treated with symptomatic and supportive treatment that may include management of electrolyte imbalances and intravenous calcium gluconate L13901",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Etidronic acid is a first generation bisphosphonate that inhibits the action of osteoclasts preventing bone resporption L13901 It has a wide therapeutic index as overdoses are not associated with severe toxicity and a long duration of action as it slowly releases from the bone L13901 Patients should be counselled regarding the risk of upper gastrointestinal adverse reactions L13901",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB01609",
                        "description": "The risk or severity of gastrointestinal bleeding and gastrointestinal ulceration can be increased when Etidronic acid is combined with Deferasirox"
                    },
                    {
                        "drugbank-id": "DB00112",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Bevacizumab is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00480",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Lenalidomide is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Thalidomide is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Sunitinib is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01270",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Ranibizumab is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB02640",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Fumagillin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB02709",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Resveratrol is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB04866",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Halofuginone is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB05288",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Anecortave acetate is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB06423",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Endostatin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB06436",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Semaxanib is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB06461",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Squalamine is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Pazopanib is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB06647",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Volociximab is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB08633",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when TNP 470 is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Pomalidomide is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB11366",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Roquinimex is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB11727",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Endostar is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB12056",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Trebananib is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB12081",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Anecortave is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB12671",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Beloranib is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB14864",
                        "description": "The risk or severity of jaw osteonecrosis and anti angiogenesis can be increased when Brolucizumab is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00213",
                        "description": "The therapeutic efficacy of Etidronic acid can be decreased when used in combination with Pantoprazole"
                    },
                    {
                        "drugbank-id": "DB00338",
                        "description": "The therapeutic efficacy of Etidronic acid can be decreased when used in combination with Omeprazole"
                    },
                    {
                        "drugbank-id": "DB00448",
                        "description": "The therapeutic efficacy of Etidronic acid can be decreased when used in combination with Lansoprazole"
                    },
                    {
                        "drugbank-id": "DB00736",
                        "description": "The therapeutic efficacy of Etidronic acid can be decreased when used in combination with Esomeprazole"
                    },
                    {
                        "drugbank-id": "DB01129",
                        "description": "The therapeutic efficacy of Etidronic acid can be decreased when used in combination with Rabeprazole"
                    },
                    {
                        "drugbank-id": "DB05351",
                        "description": "The therapeutic efficacy of Etidronic acid can be decreased when used in combination with Dexlansoprazole"
                    },
                    {
                        "drugbank-id": "DB13762",
                        "description": "The therapeutic efficacy of Etidronic acid can be decreased when used in combination with Dexrabeprazole"
                    },
                    {
                        "drugbank-id": "DB11964",
                        "description": "The therapeutic efficacy of Etidronic acid can be decreased when used in combination with Ilaprazole"
                    },
                    {
                        "drugbank-id": "DB00159",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Icosapent is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00244",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Mesalazine is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Indomethacin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00461",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Nabumetone is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00465",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Ketorolac is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00469",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Tenoxicam is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Celecoxib is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00500",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Tolmetin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00533",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Rofecoxib is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00554",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Piroxicam is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00573",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Fenoprofen is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00580",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Valdecoxib is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00586",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Diclofenac is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00605",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Sulindac is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00712",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Flurbiprofen is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00749",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Etodolac is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00784",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Mefenamic acid is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00788",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Naproxen is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Sulfasalazine is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00812",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Phenylbutazone is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00814",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Meloxicam is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00821",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Carprofen is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00861",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Diflunisal is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00936",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Salicylic acid is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00939",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Meclofenamic acid is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00945",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Acetylsalicylic acid is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00991",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Oxaprozin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01009",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Ketoprofen is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01014",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Balsalazide is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01050",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Ibuprofen is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01250",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Olsalazine is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01283",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Lumiracoxib is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01397",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Magnesium salicylate is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01399",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Salsalate is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01401",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Choline magnesium trisalicylate is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01419",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Antrafenine is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01424",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Aminophenazone is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Antipyrine is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01600",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Tiaprofenic acid is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01628",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Etoricoxib is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB02224",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Taxifolin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB03585",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Oxyphenbutazone is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB04725",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Licofelone is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Nimesulide is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB04812",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Benoxaprofen is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB04817",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Metamizole is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB04828",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Zomepirac is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB05095",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Cimicoxib is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB06725",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Lornoxicam is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB06736",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Aceclofenac is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB06737",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Zaltoprofen is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB07402",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Azapropazone is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB08439",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Parecoxib is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB08797",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Salicylamide is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB08940",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Kebuzone is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB08942",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Isoxicam is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB08951",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Indoprofen is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB08955",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Ibuproxam is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB08976",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Floctafenine is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB08981",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Fenbufen is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB08984",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Etofenamate is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB08991",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Epirizole is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB09084",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Benzydamine is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB09213",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Dexibuprofen is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB09214",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Dexketoprofen is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB09215",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Droxicam is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB09216",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Tolfenamic acid is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB09217",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Firocoxib is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB09218",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Clonixin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB09285",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Morniflumate is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Propacetamol is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB09295",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Talniflumate is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB11455",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Robenacoxib is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB11466",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Tepoxalin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB11518",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Flunixin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB12399",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Polmacoxib is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB12445",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Nitroaspirin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB12545",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Indobufen is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB12610",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Ebselen is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB13001",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Tinoridine is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB13167",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Alclofenac is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB13217",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Fentiazac is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB13232",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Suxibuzone is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB13286",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Bumadizone is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB13314",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Alminoprofen is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB13371",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Difenpiramide is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB13407",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Nifenazone is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB13432",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Lonazolac is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB13481",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Tenidap is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB13524",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Propyphenazone is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB13527",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Proglumetacin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB13538",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Guacetisal is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB13544",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Ethenzamide is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB13612",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Carbaspirin calcium is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB13629",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Mofebutazone is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB13649",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Proquazone is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB13657",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Benorilate is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB13722",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Pirprofen is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB13783",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Acemetacin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB13860",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Imidazole salicylate is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB14059",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when SC 236 is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB14060",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when NS 398 is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB14938",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Flurbiprofen axetil is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB09212",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Loxoprofen is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00017",
                        "description": "The risk or severity of hypocalcemia can be increased when Salmon calcitonin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB06773",
                        "description": "The risk or severity of hypocalcemia can be increased when Human calcitonin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB13189",
                        "description": "The risk or severity of hypocalcemia can be increased when Calcitonin porcine is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB13742",
                        "description": "The risk or severity of hypocalcemia can be increased when Elcatonin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00314",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Capreomycin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00452",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Framycetin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00479",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Amikacin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00684",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Tobramycin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00798",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Gentamicin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00955",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Netilmicin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00994",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Neomycin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01082",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Streptomycin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01172",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Kanamycin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01421",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Paromomycin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB03615",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Ribostamycin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB04263",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Geneticin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB04626",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Apramycin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB04729",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Gentamicin C1a is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB04808",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Neamine is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB06696",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Arbekacin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB08437",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Puromycin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB11512",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Dihydrostreptomycin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB11520",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Hygromycin B is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB12604",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Sisomicin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB12615",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Plazomicin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB13540",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Isepamicin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00803",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Colistin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01370",
                        "description": "The serum concentration of Etidronic acid can be decreased when it is combined with Aluminium"
                    },
                    {
                        "drugbank-id": "DB01377",
                        "description": "The serum concentration of Etidronic acid can be decreased when it is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01390",
                        "description": "The serum concentration of Etidronic acid can be decreased when it is combined with Sodium bicarbonate"
                    },
                    {
                        "drugbank-id": "DB06723",
                        "description": "The serum concentration of Etidronic acid can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB06724",
                        "description": "The serum concentration of Etidronic acid can be decreased when it is combined with Calcium carbonate"
                    },
                    {
                        "drugbank-id": "DB08938",
                        "description": "The serum concentration of Etidronic acid can be decreased when it is combined with Magaldrate"
                    },
                    {
                        "drugbank-id": "DB09104",
                        "description": "The serum concentration of Etidronic acid can be decreased when it is combined with Magnesium hydroxide"
                    },
                    {
                        "drugbank-id": "DB09281",
                        "description": "The serum concentration of Etidronic acid can be decreased when it is combined with Magnesium trisilicate"
                    },
                    {
                        "drugbank-id": "DB09481",
                        "description": "The serum concentration of Etidronic acid can be decreased when it is combined with Magnesium carbonate"
                    },
                    {
                        "drugbank-id": "DB13209",
                        "description": "The serum concentration of Etidronic acid can be decreased when it is combined with Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB13249",
                        "description": "The serum concentration of Etidronic acid can be decreased when it is combined with Magnesium silicate"
                    },
                    {
                        "drugbank-id": "DB13280",
                        "description": "The serum concentration of Etidronic acid can be decreased when it is combined with Aluminium acetoacetate"
                    },
                    {
                        "drugbank-id": "DB13322",
                        "description": "The serum concentration of Etidronic acid can be decreased when it is combined with Hydrotalcite"
                    },
                    {
                        "drugbank-id": "DB13486",
                        "description": "The serum concentration of Etidronic acid can be decreased when it is combined with Magnesium peroxide"
                    },
                    {
                        "drugbank-id": "DB13595",
                        "description": "The serum concentration of Etidronic acid can be decreased when it is combined with Almasilate"
                    },
                    {
                        "drugbank-id": "DB13626",
                        "description": "The serum concentration of Etidronic acid can be decreased when it is combined with Aluminium glycinate"
                    },
                    {
                        "drugbank-id": "DB13650",
                        "description": "The serum concentration of Etidronic acid can be decreased when it is combined with Aloglutamol"
                    },
                    {
                        "drugbank-id": "DB13829",
                        "description": "The serum concentration of Etidronic acid can be decreased when it is combined with Calcium silicate"
                    },
                    {
                        "drugbank-id": "DB14517",
                        "description": "The serum concentration of Etidronic acid can be decreased when it is combined with Aluminium phosphate"
                    },
                    {
                        "drugbank-id": "DB00325",
                        "description": "Nitroprusside can cause a decrease in the absorption of Etidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06783",
                        "description": "Prussian blue can cause a decrease in the absorption of Etidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09146",
                        "description": "Iron sucrose can cause a decrease in the absorption of Etidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09501",
                        "description": "Ferric ammonium citrate can cause a decrease in the absorption of Etidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09507",
                        "description": "Ferumoxsil can cause a decrease in the absorption of Etidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09508",
                        "description": "Ferumoxides can cause a decrease in the absorption of Etidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11171",
                        "description": "Ferric sulfate can cause a decrease in the absorption of Etidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11210",
                        "description": "Ferrous bisglycinate can cause a decrease in the absorption of Etidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11417",
                        "description": "Gleptoferron can cause a decrease in the absorption of Etidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11576",
                        "description": "Ferric oxide can cause a decrease in the absorption of Etidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB12821",
                        "description": "Perflubutane can cause a decrease in the absorption of Etidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13257",
                        "description": "Ferrous sulfate anhydrous can cause a decrease in the absorption of Etidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13381",
                        "description": "Sodium feredetate can cause a decrease in the absorption of Etidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13423",
                        "description": "Ferric hydroxide can cause a decrease in the absorption of Etidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13569",
                        "description": "Ferrous chloride can cause a decrease in the absorption of Etidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13949",
                        "description": "Ferric cation can cause a decrease in the absorption of Etidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14488",
                        "description": "Ferrous gluconate can cause a decrease in the absorption of Etidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14489",
                        "description": "Ferrous succinate can cause a decrease in the absorption of Etidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14491",
                        "description": "Ferrous fumarate can cause a decrease in the absorption of Etidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14520",
                        "description": "Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Etidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14695",
                        "description": "Ferric oxyhydroxide can cause a decrease in the absorption of Etidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB15598",
                        "description": "Ferric maltol can cause a decrease in the absorption of Etidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB12208",
                        "description": "Iron isomaltoside 1000 can cause a decrease in the absorption of Etidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00653",
                        "description": "Magnesium sulfate can cause a decrease in the absorption of Etidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09407",
                        "description": "Magnesium chloride can cause a decrease in the absorption of Etidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11110",
                        "description": "Magnesium citrate can cause a decrease in the absorption of Etidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13359",
                        "description": "Magnesium aspartate can cause a decrease in the absorption of Etidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13749",
                        "description": "Magnesium gluconate can cause a decrease in the absorption of Etidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13786",
                        "description": "Magnesium orotate can cause a decrease in the absorption of Etidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14514",
                        "description": "Magnesium levulinate can cause a decrease in the absorption of Etidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14515",
                        "description": "Magnesium lactate can cause a decrease in the absorption of Etidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00258",
                        "description": "The serum concentration of Etidronic acid can be decreased when it is combined with Calcium acetate"
                    },
                    {
                        "drugbank-id": "DB00326",
                        "description": "The serum concentration of Etidronic acid can be decreased when it is combined with Calcium glucoheptonate"
                    },
                    {
                        "drugbank-id": "DB01164",
                        "description": "The serum concentration of Etidronic acid can be decreased when it is combined with Calcium chloride"
                    },
                    {
                        "drugbank-id": "DB11093",
                        "description": "The serum concentration of Etidronic acid can be decreased when it is combined with Calcium citrate"
                    },
                    {
                        "drugbank-id": "DB11126",
                        "description": "The serum concentration of Etidronic acid can be decreased when it is combined with Calcium gluconate"
                    },
                    {
                        "drugbank-id": "DB11348",
                        "description": "The serum concentration of Etidronic acid can be decreased when it is combined with Calcium Phosphate"
                    },
                    {
                        "drugbank-id": "DB13142",
                        "description": "The serum concentration of Etidronic acid can be decreased when it is combined with Calcium glubionate anhydrous"
                    },
                    {
                        "drugbank-id": "DB13231",
                        "description": "The serum concentration of Etidronic acid can be decreased when it is combined with Calcium lactate"
                    },
                    {
                        "drugbank-id": "DB13365",
                        "description": "The serum concentration of Etidronic acid can be decreased when it is combined with Calcium lactate gluconate"
                    },
                    {
                        "drugbank-id": "DB13590",
                        "description": "The serum concentration of Etidronic acid can be decreased when it is combined with Calcium pangamate"
                    },
                    {
                        "drugbank-id": "DB13800",
                        "description": "The serum concentration of Etidronic acid can be decreased when it is combined with Calcium levulinate"
                    },
                    {
                        "drugbank-id": "DB14577",
                        "description": "The serum concentration of Etidronic acid can be decreased when it is combined with Calcium cation"
                    },
                    {
                        "drugbank-id": "DB14684",
                        "description": "The serum concentration of Etidronic acid can be decreased when it is combined with Calcium polycarbophil"
                    },
                    {
                        "drugbank-id": "DB09139",
                        "description": "The risk or severity of hypocalcemia can be increased when Etidronic acid is combined with Technetium Tc 99m oxidronate"
                    },
                    {
                        "drugbank-id": "DB00214",
                        "description": "The risk or severity of hypocalcemia can be increased when Torasemide is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00695",
                        "description": "The risk or severity of hypocalcemia can be increased when Furosemide is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00887",
                        "description": "The risk or severity of hypocalcemia can be increased when Bumetanide is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00903",
                        "description": "The risk or severity of hypocalcemia can be increased when Etacrynic acid is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB02925",
                        "description": "The risk or severity of hypocalcemia can be increased when Piretanide is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB08961",
                        "description": "The risk or severity of hypocalcemia can be increased when Azosemide is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cyclosporine is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00229",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefotiam is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00267",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefmenoxime is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00274",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefmetazole is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00282",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Pamidronic acid is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00300",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Tenofovir disoproxil is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00369",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cidofovir is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00384",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Triamterene is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00430",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefpiramide is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00438",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Ceftazidime is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00447",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Loracarbef is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00456",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefalotin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00493",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefotaxime is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00512",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Vancomycin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00515",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cisplatin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00529",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Foscarnet is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Methotrexate is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00567",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cephalexin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00577",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Valaciclovir is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00626",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Bacitracin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00681",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Amphotericin B is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00689",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cephaloglycin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00718",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Adefovir dipivoxil is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Pentamidine is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00742",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Mannitol is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00787",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Acyclovir is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00833",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefaclor is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Tacrolimus is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00923",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Ceforanide is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00958",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Carboplatin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Hydrochlorothiazide is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01066",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefditoren is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Atazanavir is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01111",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Colistimethate is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01112",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefuroxime is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01139",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefapirin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01140",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefadroxil is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01150",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefprozil is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01212",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Ceftriaxone is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01326",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefamandole is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01327",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefazolin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01328",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefonicid is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01329",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefoperazone is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01330",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefotetan is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01331",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefoxitin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01332",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Ceftizoxime is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01333",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefradine is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Lithium cation is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01413",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefepime is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01414",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefacetrile is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01415",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Ceftibuten is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01416",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefpodoxime is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Lopinavir is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB02247",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Hydrolyzed Cephalothin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB03450",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cephalothin Group is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB04570",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Latamoxef is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB04918",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Ceftobiprole is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB06590",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Ceftaroline fosamil is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB09008",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefaloridine is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB09062",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefminox is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB09299",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Tenofovir alafenamide is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB11367",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefroxadine is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB11935",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Flomoxef is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB12151",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Brincidofovir is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB13266",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefatrizine is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB13461",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefcapene is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB13470",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefodizime is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB13499",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefsulodin is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB13504",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefetamet is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB13638",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefbuperazone is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB13667",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefozopran is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB13682",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefpirome is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB13778",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefazedone is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB13821",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Ceftezole is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB13868",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Adefovir is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB14126",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Tenofovir is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB14713",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Inotersen is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01438",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Phenazopyridine is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB14507",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Lithium citrate is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB14509",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Lithium carbonate is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB15066",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Givosiran is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00399",
                        "description": "The risk or severity of adverse effects can be increased when Zoledronic acid is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00630",
                        "description": "The risk or severity of adverse effects can be increased when Alendronic acid is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The risk or severity of adverse effects can be increased when Ibandronate is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00720",
                        "description": "The risk or severity of adverse effects can be increased when Clodronic acid is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB00884",
                        "description": "The risk or severity of adverse effects can be increased when Risedronic acid is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB01133",
                        "description": "The risk or severity of adverse effects can be increased when Etidronic acid is combined with Tiludronic acid"
                    },
                    {
                        "drugbank-id": "DB06255",
                        "description": "The risk or severity of adverse effects can be increased when Etidronic acid is combined with Incadronic acid"
                    },
                    {
                        "drugbank-id": "DB05829",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB14513",
                        "description": "Magnesium can cause a decrease in the absorption of Etidronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}